Compile Data Set for Download or QSAR
Report error Found 100 Enz. Inhib. hit(s) with all data for entry = 671
TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286162(US9518000, Example 55 | 4-(4-(2-chloro-3- (trifluo...)
Affinity DataEC50:  170nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286114(US9518000, Example 7 | 4-(4-(3-methyl-5- (trifluor...)
Affinity DataEC50:  230nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286124(US9518000, Example 17 | 4-(4-(3-(4- fluorophenoxy)...)
Affinity DataEC50:  250nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286125(US9518000, Example 18 | 4-(4-(3-chloro-5- (trifluo...)
Affinity DataEC50:  250nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286140(US9518000, Example 33 | 4-(4-(2-fluoro-5- (trifluo...)
Affinity DataEC50:  260nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286121(US9518000, Example 14 | 4-(4-(2-phenoxy- benzyloxy...)
Affinity DataEC50:  270nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286186(US9518000, Example 79 | 3-(4-(3-Fluoro-5-phenoxybe...)
Affinity DataEC50:  270nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286198(US9518000, Example 91 | 2-((4-((3-Fluoro-5-phenoxy...)
Affinity DataEC50:  280nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286153(US9518000, Example 46 | 4-(4-(2-fluoro-3- (trifluo...)
Affinity DataEC50:  290nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286150(US9518000, Example 43 | 4-(4-(4-methoxy-2- (triflu...)
Affinity DataEC50:  320nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286155(US9518000, Example 48 | 4-(4-(biphenyl- 2-ylmethox...)
Affinity DataEC50:  320nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286188(US9518000, Example 81 | 3-(4-(3-fluoro-5-(4- fluor...)
Affinity DataEC50:  350nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286122(US9518000, Example 15 | 4-(4-(3-phenoxy- benzyloxy...)
Affinity DataEC50:  360nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286173(US9518000, Example 66 | methyl 4-(4- ((4-fluoro-4'...)
Affinity DataEC50:  370nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286203(US9518000, Example 97 | US9518000, Example 96)
Affinity DataEC50:  380nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286135(US9518000, Example 28 | 4-(4-(3-fluoro-5- (trifluo...)
Affinity DataEC50:  390nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286141(US9518000, Example 34 | 4-(4-(3-fluoro-5- phenoxyb...)
Affinity DataEC50:  400nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286190(US9518000, Example 83 | 4-(4-(5-Fluoro-2-phenoxybe...)
Affinity DataEC50:  400nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286142(US9518000, Example 35 | 4-(4-(3-fluoro-5- isopropo...)
Affinity DataEC50:  440nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286113(US9518000, Example 6 | 4-(4-(3-chloro-5- phenoxybe...)
Affinity DataEC50:  450nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286202(US9518000, Example 95 | 2-((4-((3-Phenoxybenzyl)ox...)
Affinity DataEC50:  510nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286126(US9518000, Example 19 | 4-(4-(5-chloro-2- (trifluo...)
Affinity DataEC50:  520nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286110(US9518000, Example 3 | 4-(4-((5-chloro- 2,2-dimeth...)
Affinity DataEC50:  530nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286157(US9518000, Example 50 | 4-(4-(3-(trifluoro- methyl...)
Affinity DataEC50:  540nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286207(US9518000, Example 100 | 2-(2-(4-((3-Fluoro-5-phen...)
Affinity DataEC50:  570nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286139(US9518000, Example 32 | 4-(4-(3-(4- chlorophenoxy)...)
Affinity DataEC50:  590nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286116(US9518000, Example 9 | 4-(4-(4,6- dichloro-2,3- di...)
Affinity DataEC50:  600nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286199(US9518000, Example 92)
Affinity DataEC50:  600nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286166(US9518000, Example 59 | 4-(4-(2,3,6- trichlorobenz...)
Affinity DataEC50:  610nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286133(US9518000, Example 26 | 4-(4-(3-(trifluoro- methox...)
Affinity DataEC50:  620nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286201(US9518000, Example 94 | (E)-4-(4-((3-Phenoxybenzyl...)
Affinity DataEC50:  630nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286132(US9518000, Example 25 | 4-(4-(3-fluoro-5- (trifluo...)
Affinity DataEC50:  640nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286123(US9518000, Example 16 | 4-(4-(3-(2- fluorophenoxy)...)
Affinity DataEC50:  640nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286111(US9518000, Example 4 | 4-(4-(3,5-dichloro- benzylo...)
Affinity DataEC50:  650nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286156(US9518000, Example 49 | 4-(4-(2-(trifluoro- methyl...)
Affinity DataEC50:  660nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286159(US9518000, Example 52 | 4-(4-(5-chloro-2- fluorobe...)
Affinity DataEC50:  690nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286152(US9518000, Example 45 | 4-(4-(3-chloro-2- fluorobe...)
Affinity DataEC50:  710nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286127(US9518000, Example 20 | 4-(4-(2-(trifluoro- methox...)
Affinity DataEC50:  710nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286129(US9518000, Example 22 | 4-(4-(3-chloro-5- fluorobe...)
Affinity DataEC50:  730nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286168(US9518000, Example 61 | 4-(4-(3- (thiophen-2-yl) b...)
Affinity DataEC50:  750nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286164(US9518000, Example 57 | 4-(4-(biphenyl- 3-ylmethox...)
Affinity DataEC50:  770nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286169(US9518000, Example 62 | 4-(4-(5-bromo-2- methylben...)
Affinity DataEC50:  810nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286146(US9518000, Example 39 | 4-(4-(3-benzoyl- benzyloxy...)
Affinity DataEC50:  820nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286136(4-(4-(2-methoxy- 5-(trifluorometh- oxy)benzyloxy) ...)
Affinity DataEC50:  850nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286176(US9518000, Example 69 | 3-Methyl-4-(4-(3-phenoxybe...)
Affinity DataEC50:  870nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286200(US9518000, Example 93)
Affinity DataEC50:  880nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286138(US9518000, Example 31 | 4-(4-(3-chloro-5- methoxyb...)
Affinity DataEC50:  900nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286151(US9518000, Example 44 | 4-(4-(5-fluoro-2- (trifluo...)
Affinity DataEC50:  930nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286185(US9518000, Example 78 | 2-((4-((3-chloro-5- (trifl...)
Affinity DataEC50:  940nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286189(US9518000, Example 82 | 3-(4-(1-(3-fluoro-5-(4- fl...)
Affinity DataEC50:  980nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

Displayed 1 to 50 (of 100 total ) | Next | Last >>
Jump to: